8th Complement-based Drug Development Summit

Dec. 10, 2024 - Dec. 12, 2024

Achieving Efficacy and Exploring Indication Expansion for Complement Inhibitors

The complement community is shifting gear, with more companies than ever targeting alternative complement proteins for their therapies, allowing for a larger range of diseases to be targeted.

With more assets in ophthalmology, neurology, and oncology than ever before, the complement-based therapeutics field has everyone asking the same question: which inhibitor will be the next to harness the complement system for the development of groundbreaking therapies?

From the discovery of new pathways to target to post-approval indication expansion, the immunology landscape is primed to capitalize on the huge strides being taken in achieving efficacy and approving the safety profile of complement-based therapeutics.

Date and Time: Tuesday, 10 December 2024 at 09:00 to Thursday, 12 December 2024 at 18:00

Latest from Events